Aura Biosciences, Inc. (AURA) vs Faeth Therapeutics, Inc. (FTH)

A side-by-side comparison of Aura Biosciences, Inc. and Faeth Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aura Biosciences, Inc. logo
AURA
Aura Biosciences, Inc.
$645M
$6.24HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Faeth Therapeutics, Inc. logo
FTH
Faeth Therapeutics, Inc.
$712M
$27.61HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

Total return — AURA vs FTH

growth of $100 · dividends reinvested · last 5y
AURA -58.0% (-15.9%/yr)FTH -84.4% (-31.0%/yr)AURA compounded faster over this window
050100150Start $10020222023202420252026$42$16
AURA FTH

AURA vs FTH: by the numbers

  • •FTH is the larger company ($712M vs $645M market cap).

Metrics side by side

Valuation

MetricAURAFTH
P/B ratio2.054.12

Profitability

MetricAURAFTH
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-41.56%-113.05%
ROIC-42.02%-110.62%

Growth (annualized)

MetricAURAFTH
Total return CAGR (5Y)N/A-31.75%

Go deeper

Full AURA analysisFull FTH analysisInteractive comparison tool

Dig into the metrics

Aura Biosciences ROEFaeth Therapeutics ROEAura Biosciences operating marginFaeth Therapeutics operating marginAura Biosciences revenue growthFaeth Therapeutics revenue growthAura Biosciences free cash flowFaeth Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.